European Public Health Alliance (EPHA) is organising its 6th Edition of the Universal Access and Affordable Medicines (A2M) Forum. The event will be held on December 8 from 09:30 to 13:00 at Scotland House, Brussels.
The event begins with opening remarks and an introductory statement by Sarah Garner, Senior Policy Advisor for Access to Medicines and Health Products from WHO Regional Office for Europe, followed by two plenary sessions moderated by communications expert Tasmin Rose.
The first session addresses the development of and access to new antibiotics which are needed as part of the toolbox to address increasing antimicrobial resistance (AMR). It also focuses on the timely access to existing antibiotics alongside measures to ensure they are used prudently. This session will discuss more effective and fairer alternative incentives that could address both the lack of new antibiotics and the availability of old ones.
The second session focuses on fair medicine pricing and ensuring the transparency of pharmaceutical R&D costs. Convening experts from different areas, this session will discuss ways forward to improve transparency of pharmaceutical R&D costs in the context of the revision of the EU pharmaceutical legislation.
Confirmed speakers include:
- Milka Sokolović | Director General, European Public Health Alliance (EPHA)
- Sarah Garner | Senior Policy Advisor, Access to Medicines and Health Products, WHO Regional Office for Europe
- Helle Aagard | ReAct, Action on Antibiotic Resistance
- Anna Prokupkova | Health Policy Advisor – Greens/EFA Group at European Parliament
- Javier de la Cueva | Lawyer specialised in free intellectual property licenses
- Anne Hendrickx | Advisor in the Research department of Solidaris (Belgian mutual fund), Fair pricing calculator